Treatment of Unruptured Cerebral Aneurysms in the 21st Century: Coils, Stents and Beyond
Guilherme Dabus, M.D., with Miami Neuroscience Center and Miami Cardiac & Vascular Institute, will discuss the symptoms to look for when considering a diagnosis of unruptured cerebral aneurysms and what to consider to formulate a treatment strategy for patients with unruptured cerebral aneurysms.
Adult and Pediatric Neurologists, Neurosurgeons, Stroke Neurologists, Neuroradiologists, Diagnostic Radiologists, Critical Care Physicians, Neurointensivists, Emergency Medicine Physicians, Internal Medicine Physicians, Interventional Neuroradiologists, Family Physicians, General Internists, Rehabilitation and Pain Management Specialists, as well as other specialists interested in the field of neuroscience.
- Explain the epidemiology and natural course of unruptured cerebral aneurysms.
- Recognize the symptoms associated with unruptured cerebral aneurysms.
- Implement severity scores for unruptured cerebral aneurysms.
- Formulate a treatment strategy for patients with unruptured cerebral aneurysms.
Guilherme Dabus, M.D.
Medical Director, Fellowship Program in Interventional Neuroradiology and Endovascular Neurosurgery
Miami Cardiac & Vascular Institute and Baptist Hospital of Miami
Clinical Associate Professor of Radiology, Neurology and Neurosurgery
Florida International University Herbert Wertheim College of Medicine
MIAMI NEUROSCIENCE SYMPOSIUM PLANNING COMMITTEE
Kevin Abrams, M.D., indicated that he is a consultant for and shareholder in Keystone Heart.
Guilherme Dabus, M.D., indicated that he is a consultant for Microvention/Terumo, Medtronic, Penumbra and Cerenovus, and on the speakers bureau for Microvention/Terumo, Medtronic and Penumbra. He is a proctor for Medtronic. Dr. Dabus is also a shareholder in Surpass Medical/Stryker, Medina/Medtronic, InNeuro Co and Three Rivers Medical.
Daniel D’Amour, M.D., Felipe De Los Rios, M.D., Karel Fuentes, M.D., Sergio Gonzalez-Arias, M.D., Ph.D., Kunal Patel, M.S., Amy K. Starosciak, Ph.D., and Jayme Strauss, R.N., MSN, indicated that neither they nor their spouse/partner have relevant financial relationships with commercial interest companies, and they will not include off-label or unapproved product usage in their presentation(s) or discussion(s).
Bruno V. Gallo, M.D., indicated that he is on speakers bureau for Teva Pharmaceuticals and Sunovion Pharmaceuticals. He receives grant support for Medtronic International, Pfizer Pharmaceuticals, Glaxo-SmithKline and St. Jude Medical, Inc. Dr. Gallo serves as a consultant for Cyberonics, Teva Pharmaceuticals, St. Jude Medical, ONS Inc. and Sugimon LLC.
Italo Linfante, M.D., indicated that he is a consultant for Medtronic, Stryker and Penumbra. He is a shareholder in InNeuro Co.
Alberto Pinzon-Ardila, M.D., indicated that he is on the speakers bureau for Sunovion Pharmaceuticals and UCB.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.50 AMA PRA Category 1 Credit™
- 0.50 General certificate of attendance
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.